The end of a breast implant product linked to a rare type of cancer is seemingly finally here. On Wednesday, the Food and Administration said it had pushed for a recall of Biocell textured breast implants, sold by the pharmaceutical company Allergan. Allergan announced the same day that it would pull all remaining…
Read more…
Source : A Breast Implant Linked to Rare Cancer Is Finally Off the Market
